Learn More
Medchemexpress LLC ART558 | 2603528-97-6 | 99.97% | C21H21F3N4O2 | 100 MG

Supplier: Medchemexpress LLC HY141520100MG
ART558 is a potent, selective, and allosteric DNA polymerase theta (Polθ) inhibitor with an IC50 of 7.9 nM. It elicits BRCA-gene synthetic lethality and DNA damage, making it suitable for cancer research, including breast cancer.
- Elicits BRCA-gene synthetic lethality and DNA damage.
- Inhibits Theta-Mediated End Joining without affecting Non-Homologous End Joining.
- Enhances the effects of a PARP inhibitor.
- Increases biomarkers of single-stranded DNA and synthetic lethality in 53BP1-defective cells.
- Prolongs the residence time of YFP-tagged full-length Polθ at sites of laser-induced DNA damage.
- Shows antiproliferative activity against human BRCA-2 deficient DLD-1 cells (EC50 = 0.8 nM).
- Inhibits microhomology-mediated end joining in HEK293 cells (EC50 = 180 nM).
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.